Reglagene Holding, Inc. products

Pipeline

Model RGN3118 - Anti-Cancer for Microtubule Targeting Agent

RGN3118 is a potent, orally administered, blood-brain barrier penetrant therapy that has been optimized for the treatment of high-grade gliomas, such as glioblastoma as well as brain metastases from breast, lung, and melanoma cancers.

Reglagene - Model RGNXXXX - Anti-Infectivity & Anti-Inflammation for Microtubule Targeting Agent

RGNXXXX is a potent, orally administered, blood-brain barrier penetrant therapy that is being optimized for the treatment of anti-infectivity and neuro-inflammation, such as acute COVID-19 and neuro-inflammatory diseases, respectfully.

Reglagene - Model RGNXXXX - Age Related Macular Degeneration for Microtubule Targeting Agent

RGNXXXX is a potent, topical eye drop for the treatment of wet AMD. The anti-neovascular effects reduces leaky blood vessels in the eyes.